Boston Scientific Corporation
BSX
Helyezés a részvények között
#409
Ez a cégleírás csak angol nyelven érhető el.
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Részvényárfolyam
$41.88
Utolsó szinkronizálás: 2026-10-30
Piaci kapitalizáció
$60.69B
Változás (1 nap)
-1.89%
Változás (1 év)
-58.42%
Ország
US
Részvényadatok: Financial Modeling Prep·Frissítve: ·Nem befektetési tanács·Így számolunk
Kereskedés Boston Scientific Corporation (BSX)
Kategória
Healthcare
Boston Scientific Corporation (BSX) P/B aránya
P/B arány ekkor: November 2026 TTM: 2.44
Boston Scientific Corporation legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi könyv szerinti árfolyam aránya (P/B, TTM) 2.44. 2025 végén ez az arány 5.83 volt.
P/B arány története a(z) Boston Scientific Corporation esetén 2000 és 2026 között
P/B arány az év végén
| Év | P/B arány | Változás |
|---|---|---|
| 2026 (TTM) | 2.44 | -58.16% |
| 2025 | 5.83 | -3.52% |
| 2024 | 6.04 | 38.59% |
| 2023 | 4.36 | 15.67% |
| 2022 | 3.77 | 3.62% |
| 2021 | 3.63 | 9.38% |
| 2020 | 3.32 | -26.72% |
| 2019 | 4.53 | -18.94% |
| 2018 | 5.59 | 15.46% |
| 2017 | 4.84 | 11.08% |
| 2016 | 4.36 | 12.58% |
| 2015 | 3.87 | 51.08% |
| 2014 | 2.56 | 4.01% |
| 2013 | 2.47 | 110.13% |
| 2012 | 1.17 | 65.28% |
| 2011 | 0.71 | -30.21% |
| 2010 | 1.02 | -7.80% |
| 2009 | 1.10 | 24.98% |
| 2008 | 0.88 | -22.93% |
| 2007 | 1.15 | -19.92% |
| 2006 | 1.43 | -69.73% |
| 2005 | 4.73 | -36.01% |
| 2004 | 7.39 | -30.56% |
| 2003 | 10.64 | 52.20% |
| 2002 | 6.99 | 40.54% |
| 2001 | 4.97 | 73.37% |
| 2000 | 2.87 | 0.00% |
P/B arány hasonló vállalatoknál vagy versenytársaknál
| Vállalat | P/B arány | P/B arány különbség | Ország |
|---|---|---|---|
| 3.6116 | 48.05% |
US
|
|
| 2.4596 | 0.82% |
IE
|
|
| 4.7555 | 94.94% |
US
|
|
| 2.513 | 3.01% |
DE
|
|
| 4.9948 | 104.75% |
US
|
Boston Scientific Corporation P/B aránya: kérdések és válaszok
Mennyi a(z) Boston Scientific Corporation P/B aránya?
A legfrissebb adatok szerint (2026. nov.) a(z) Boston Scientific Corporation P/B aránya 2.44.
Mennyi volt a(z) Boston Scientific Corporation 2025. évi P/B aránya?
5.83 volt a(z) Boston Scientific Corporation 2025. évi P/B aránya, az előző évben (2024) pedig 6.04.
Hogyan változott a(z) Boston Scientific Corporation P/B aránya 2020 óta?
2020 és 2025 között a(z) Boston Scientific Corporation P/B aránya 2024 folyamán érte el a csúcsát (6.04), 2020 folyamán pedig a mélypontját (3.32).
Hogyan alakul a(z) Boston Scientific Corporation P/B aránya a hasonló vállalatokhoz képest?
A fenti 5 hasonló vállalat mindegyikénél alacsonyabb a(z) Boston Scientific Corporation P/B aránya (2.44). Közülük a legmagasabb érték: 4.99 (Edwards Lifesciences Corporation).